{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T16:09:06Z","timestamp":1776614946155,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003952","name":"Ministry for Food, Agriculture, Forestry and Fisheries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["RS-2023-NR076878"],"award-info":[{"award-number":["RS-2023-NR076878"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.micpath.2025.108209","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T16:40:59Z","timestamp":1764088859000},"page":"108209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Augmentation of humoral and cell-mediated immune responses by recombinant rabies virus expressing canine Fc"],"prefix":"10.1016","volume":"210","author":[{"given":"Jae-Yeon","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maheswaran","family":"Easwaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-4924","authenticated-orcid":false,"given":"Hyun-Jin","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.108209_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.91","article-title":"Rabies","volume":"3","author":"Fooks","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.micpath.2025.108209_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fvets.2017.00009","article-title":"Elimination of dog-mediated human rabies deaths by 2030: needs assessment and alternatives for progress based on dog vaccination","volume":"4","author":"Wallace","year":"2017","journal-title":"Front. Vet. Sci."},{"key":"10.1016\/j.micpath.2025.108209_bib3","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/01652176.2017.1343516","article-title":"Rabies - epidemiology, pathogenesis, public health concerns and advances in diagnosis and control: a comprehensive review","volume":"37","author":"Singh","year":"2017","journal-title":"Vet. Q."},{"key":"10.1016\/j.micpath.2025.108209_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2024.100452","article-title":"Rabies control in Bangladesh and prediction of human rabies cases by 2030: a one health approach","volume":"27","author":"Ghosh","year":"2024","journal-title":"The Lancet Regional Health - Southeast Asia"},{"key":"10.1016\/j.micpath.2025.108209_bib5","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2025.108209_bib6","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1586\/erv.11.140","article-title":"From brain passage to cell adaptation: the road of human rabies vaccine development","volume":"10","author":"Wu","year":"2011","journal-title":"Expet Rev. Vaccine"},{"key":"10.1016\/j.micpath.2025.108209_bib7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(13)62707-5","article-title":"Current status of rabies and prospects for elimination","volume":"384","author":"Fooks","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.micpath.2025.108209_bib8","article-title":"Advances in infectious disease vaccine adjuvants","volume":"10","author":"Fan","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2025.108209_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2025.108209_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94653-z","article-title":"A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples","volume":"11","author":"Sancilio","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.micpath.2025.108209_bib12","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41573-022-00501-8","article-title":"Avidity in antibody effector functions and biotherapeutic drug design","volume":"21","author":"Oostindie","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.micpath.2025.108209_bib13","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nri856","article-title":"Roles of Fc receptors in autoimmunity","volume":"2","author":"Takai","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3390\/idr14060097","article-title":"Ecological and socioeconomic factors in the occurrence of rabies: a forgotten scenario","volume":"14","author":"Subedi","year":"2022","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2025.108209_bib15","first-page":"A140","article-title":"New human rabies vaccines in the pipeline. Vaccine 37 Suppl","volume":"1","author":"Fooks","year":"2019"},{"key":"10.1016\/j.micpath.2025.108209_bib16","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1503\/cmaj.071326","article-title":"Human rabies encephalitis following bat exposure: failure of therapeutic coma","volume":"178","author":"McDermid","year":"2008","journal-title":"CMAJ (Can. Med. Assoc. J.)"},{"key":"10.1016\/j.micpath.2025.108209_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2249.2012.04592.x","article-title":"Developments in rabies vaccines","volume":"169","author":"Hicks","year":"2012","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib18","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1080\/21645515.2021.1976580","article-title":"Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection","volume":"17","author":"Gunn","year":"2021","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2025.108209_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/01652176.2020.1773006","article-title":"Immunization with porcine epidemic diarrhea virus harbouring Fc domain of IgG enhances antibody production in pigs","volume":"40","author":"Park","year":"2020","journal-title":"Vet. Q."},{"key":"10.1016\/j.micpath.2025.108209_bib20","doi-asserted-by":"crossref","DOI":"10.3791\/50171-v","article-title":"Generation of stable human cell lines with Tetracycline-inducible (Tet-on) shRNA or cDNA expression","author":"Gomez-Martinez","year":"2013","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.micpath.2025.108209_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.chom.2019.12.012","article-title":"Structural analysis of rabies virus Glycoprotein reveals pH-Dependent conformational changes and interactions with a neutralizing antibody","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micpath.2025.108209_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.virusres.2016.04.014","article-title":"Immunization with avian metapneumovirus harboring chicken Fc induces higher immune responses","volume":"220","author":"Paudel","year":"2016","journal-title":"Virus Res."},{"key":"10.1016\/j.micpath.2025.108209_bib23","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1016\/j.vaccine.2020.09.058","article-title":"Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.108209_bib24","first-page":"326","article-title":"NIH potency Test for Rv-Fc and Rv-K based candidate anti-rabies vaccine produced at Komipharm International Co","volume":"7","author":"Aga","year":"2016","journal-title":"Ltd. Korea. J. Vacc.Vacc."},{"key":"10.1016\/j.micpath.2025.108209_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.976220","article-title":"Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice","volume":"13","author":"Hua","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.micpath.2025.108209_bib26","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1128\/JVI.00995-13","article-title":"Reinvestigating the role of IgM in rabies virus postexposure vaccination","volume":"87","author":"Dorfmeier","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.108209_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.imlet.2009.06.003","article-title":"IgM in microbial infections: taken for granted?","volume":"125","author":"Racine","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.micpath.2025.108209_bib28","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3389\/fimmu.2020.01513","article-title":"The role of dendritic cells during infections caused by highly prevalent viruses","volume":"11","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib29","doi-asserted-by":"crossref","first-page":"68","DOI":"10.7774\/cevr.2015.4.1.68","article-title":"Cellular immune response following pre-exposure and postexposure rabies vaccination by intradermal and intramuscular routes","volume":"4","author":"Venkataswamy","year":"2015","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.micpath.2025.108209_bib30","article-title":"Enhanced humoral and cellular immune responses elicited by adenoviral delivery of SARS-CoV-2 receptor-binding motif fused to human Fc","volume":"12","author":"Lee","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.micpath.2025.108209_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4049\/jimmunol.164.1.64","article-title":"Synergistic effects of IL-4 and IL-18 on IL-12-dependent IFN-gamma production by dendritic cells","volume":"164","author":"Fukao","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib32","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.4049\/jimmunol.166.7.4446","article-title":"Inducible expression of Stat4 in dendritic cells and macrophages and its critical role in innate and adaptive immune responses","volume":"166","author":"Fukao","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib33","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.jaci.2009.12.980","article-title":"Overview of the immune response","volume":"125","author":"Chaplin","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fimmu.2019.00529","article-title":"Role of the IgM Fc receptor in immunity and tolerance","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.108209_bib35","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12257-012-0711-0","article-title":"Tailoring immunoglobulin Fc for highly potent and serum-stable therapeutic antibodies","volume":"18","author":"Jung","year":"2013","journal-title":"Biotechnol. Bioproc. Eng."},{"key":"10.1016\/j.micpath.2025.108209_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004846","article-title":"Post-Marketing surveillance of human rabies diploid cell Vaccine (Imovax) in the Vaccine Adverse Event Reporting System (VAERS) in the United States, 1990\u20122015","volume":"10","author":"Moro","year":"2016","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.micpath.2025.108209_bib37","first-page":"1","article-title":"Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization practices","volume":"57","author":"Manning","year":"2008","journal-title":"MMWR Recomm. Rep. (Morb. Mortal. Wkly. Rep.)"},{"key":"10.1016\/j.micpath.2025.108209_bib38","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.vaccine.2019.02.083","article-title":"Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines","volume":"37","author":"Quiambao","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.108209_bib39","article-title":"Safety comparison of four types of rabies vaccines in patients with WHO category II animal exposure: an observation based on different age groups","volume":"95","author":"Peng","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.micpath.2025.108209_bib40","first-page":"20","article-title":"Sequential adaptation of vero cell lines in Serum free medium for fixed rabies virus propagation","volume":"8","author":"Mohammed","year":"2021","journal-title":"Int. J. Appl. Sci. Res. Rev."},{"key":"10.1016\/j.micpath.2025.108209_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2022.101728","article-title":"Protocol to isolate and enrich mouse splenic naive CD4+ T cells for in vitro CD4+ CD8\u03b1\u03b1+ cell induction","volume":"3","author":"Harada","year":"2022","journal-title":"STAR Protoc."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009349?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009349?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:24:20Z","timestamp":1773894260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025009349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"alternative-id":["S0882401025009349"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108209","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Augmentation of humoral and cell-mediated immune responses by recombinant rabies virus expressing canine Fc","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108209"}}